BBVA
KYNB

Banco Bilbao Vizcaya Argentaria’s Kyntra Bio KYNB Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-514
Closed -$521K – 709
2020
Q2 		$521K Hold
514
– – 0.02% 545
2020
Q1 		$446K Hold
514
– – 0.02% 508
2019
Q4 		$551K Buy
+514
New +$525K 0.02% 514

Other funds holding KYNB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's KYNB Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Kyntra Bio (KYNB) in Q3 2020, closing a stake of 514 shares — an estimated $521K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in KYNB in Q4 2019 and held it in 3 quarters. The position peaked at $551K in Q4 2019. 208 funds tracked by Wall St. Rank hold KYNB as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Kyntra Bio position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 514 Kyntra Bio shares in Q3 2020, an estimated $521K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Kyntra Bio in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Kyntra Bio position peaked at $551K in Q4 2019.
  • 208 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.